Mesoblast wins key backing from US drugmaker
The embattled stem cell biotech has seen a major US drug company becoming a cornerstone investor and taking an option over two of its main products.
-
Brian Robins
Never heard of the Rae family? They just made over $300m
One of the richest families in the country, the low-profile Rae family of Perth, has pocketed more than $300 million by selling out to Caltex Australia.
Bellamy's woes self-inflicted, say rivals as its fate hangs in the balance
Key rivals such as Bega and A2 Milk have sought to distance themselves from the woes afflicting Bellamy's as its trading halt has been extended for another three weeks while supplier contracts are renegotiated
ACCC halts investigation as GrainCorp cuts levy
Against the backdrop of a bumper grain crop, Graincorp has dropped a charge for delivering grain to competitor ports following concerns from the competition regulator it could be discriminatory.
Portland smelter assistance to come on top of existing $100m-plus annual subsidy
Extra government support to keep the struggling Portland aluminium smelter open will add to the $100 million-plus Victorians are already paying as an annual subsidy to Alcoa, the operator of the works.
Sirtex boss steps aside after pocketing $2.1m from share sale
Gilman Wong has been forced to step aside as chief executive of cancer treatment outfit Sirtex Medical following shareholder demands for an investigation into the sale of shares two months ago.
Santos slumps on latest share raising
Santos stock has slumped below the price of its latest $1.5 billion share placement, which came just a matter of months after the troubled oil and gas group appeared to signal it would not need to tap investors for more funds.
Sirtex queried about weak sales a week before estimates cut
Cancer treatment group Sirtex Medical was questioned by the stock exchange over weak sales a week before the company confirmed that sales growth had all but disappeared.
Caltex profits from rising sales of premium fuels
Strong sales of premium petrol products has helped oil refiner and distributor Caltex to raise its full year profit forecast, as it also benefits from the higher oil price lifting inventory values.
Sirtex bear still wary despite share price dive
The warning signs were there for all to see ahead of a trading update last week that slashed hundreds of millions of dollars off the market worth of biotech outfit Sirtex.
Search pagination